Skip to main content
Veterinary Medicines

Evalon (--) - Suspension and solvent for oral spray

Authorised
  • Eimeria acervulina, strain 003, Live
  • Eimeria maxima, strain 013, Live
  • Eimeria necatrix, strain 033, Live
  • Eimeria brunetti, strain 034, Live
  • Eimeria tenella, strain 004, Live

Product identification

Medicine name:
Evalon (--) - Suspension and solvent for oral spray
Active substance:
  • Eimeria acervulina, strain 003, Live
  • Eimeria maxima, strain 013, Live
  • Eimeria necatrix, strain 033, Live
  • Eimeria brunetti, strain 034, Live
  • Eimeria tenella, strain 004, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria acervulina, strain 003, Live
    Presentation_strength:332-450 oocysts Reference:Hse Comments:Suspension Index:0
  • Eimeria maxima, strain 013, Live
    Presentation_strength:196-265 oocysts Reference:Hse Comments:Suspension Index:1
  • Eimeria necatrix, strain 033, Live
    Presentation_strength:340-460 oocysts Reference:Hse Comments:Suspension Index:2
  • Eimeria brunetti, strain 034, Live
    Presentation_strength:213-288 oocysts Reference:Hse Comments:Suspension Index:3
  • Eimeria tenella, strain 004, Live
    Presentation_strength:276-374 oocysts Reference:Hse Comments:Suspension Index:4
Pharmaceutical form:
This information is not available for this product.
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Suspension: vial (glass); Solvent: vial (PP), Package_size:Suspension: 1 vial; Solvent 1 vial, Content:Suspension: 70 ml (10000 doses); Solvent: 500 ml
  • Packaging:Suspension: vial (glass); Solvent: vial (PP), Package_size:Suspension: 1 vial; Solvent: 1 vial, Content:Suspension: 7 ml (1000 doses); Solvent: 50 ml
  • Packaging:Suspension: vial (glass); Solvent: vial (PP), Package_size:Suspension: 1 vial; Solvent: 1 vial, Content:Suspension: 35 ml (5000 doses); Solvent: 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra, S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 27/02/2024
Download
Bulgarian (PDF)
Published on: 27/02/2024
Croatian (PDF)
Published on: 27/02/2024
Czech (PDF)
Published on: 27/02/2024
Danish (PDF)
Published on: 27/02/2024
Dutch (PDF)
Published on: 27/02/2024
Estonian (PDF)
Published on: 27/02/2024
Finnish (PDF)
Published on: 27/02/2024
French (PDF)
Published on: 27/02/2024
German (PDF)
Published on: 27/02/2024
Greek (PDF)
Published on: 27/02/2024
Hungarian (PDF)
Published on: 27/02/2024
Icelandic (PDF)
Published on: 27/02/2024
Italian (PDF)
Published on: 27/02/2024
Latvian (PDF)
Published on: 5/04/2024
Lithuanian (PDF)
Published on: 5/04/2024
Maltese (PDF)
Published on: 27/02/2024
Norwegian (PDF)
Published on: 27/02/2024
Polish (PDF)
Published on: 5/04/2024
Portuguese (PDF)
Published on: 27/02/2024
Romanian (PDF)
Published on: 27/02/2024
Slovak (PDF)
Published on: 27/02/2024
Slovenian (PDF)
Published on: 27/02/2024
Spanish (PDF)
Published on: 27/02/2024
Swedish (PDF)
Published on: 27/02/2024

ema-puar-evalon-v-4013-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."